These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 16077146

  • 1. Haemoglobin level and vascular access survival in haemodialysis patients.
    Garrancho JM, Kirchgessner J, Arranz M, Klinkner G, Rentero R, Ayala JA, Marcelli D.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2453-7. PubMed ID: 16077146
    [Abstract] [Full Text] [Related]

  • 2. Risk factors of vascular access failure in patients on hemodialysis.
    Gheith OA, Kamal MM.
    Iran J Kidney Dis; 2008 Oct; 2(4):201-7. PubMed ID: 19377238
    [Abstract] [Full Text] [Related]

  • 3. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
    Portolés J, López-Gómez JM, Aljama P.
    Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
    [Abstract] [Full Text] [Related]

  • 4. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ, Viedma G, Sánchez Perales MC, Borrego FJ, Borrego J, Pérez del Barrio P, Gil Cunquero JM, Liébana A, Pérez Bañasco V.
    Nefrologia; 2005 Feb; 25(3):307-14. PubMed ID: 16053012
    [Abstract] [Full Text] [Related]

  • 5. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Kimata N, Akiba T, Pisoni RL, Albert JM, Satayathum S, Cruz JM, Akizawa T, Andreucci VE, Young EW, Port FK.
    Nephrol Dial Transplant; 2005 May; 20(5):927-35. PubMed ID: 15728270
    [Abstract] [Full Text] [Related]

  • 6. Vascular access for hemodialysis: the impact on morbidity and mortality.
    Di Iorio BR, Bellizzi V, Cillo N, Cirillo M, Avella F, Andreucci VE, De Santo NG.
    J Nephrol; 2004 May; 17(1):19-25. PubMed ID: 15151255
    [Abstract] [Full Text] [Related]

  • 7. [Prospective monitoring of vascular access in hemodialysis by means of a multidisciplinary team].
    Gruss E, Portolés J, Jiménez P, Hernández T, Rueda JA, del Cerro J, Lasala M, Tato A, Gago MC, Martínez S, Velayos P.
    Nefrologia; 2006 May; 26(6):703-10. PubMed ID: 17227248
    [Abstract] [Full Text] [Related]

  • 8. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW, Dialysis Outcomes and Practice Patterns Study.
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [Abstract] [Full Text] [Related]

  • 9. The effect of hemoglobin level on arteriovenous fistula survival in Iranian hemodialysis patients.
    Khavanin Zadeh M, Gholipour F, Hadipour R.
    J Vasc Access; 2008 Dec; 9(2):133-6. PubMed ID: 18609530
    [Abstract] [Full Text] [Related]

  • 10. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
    Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA.
    Eur Heart J; 2006 Jun; 27(12):1440-6. PubMed ID: 16717081
    [Abstract] [Full Text] [Related]

  • 11. Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts.
    Gradzki R, Dhingra RK, Port FK, Roys E, Weitzel WF, Messana JM.
    Am J Kidney Dis; 2001 Dec; 38(6):1240-4. PubMed ID: 11728956
    [Abstract] [Full Text] [Related]

  • 12. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
    Lee YK, Koo JR, Kim JK, Park II, Joo MH, Yoon JW, Noh JW, Vaziri ND.
    Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
    [Abstract] [Full Text] [Related]

  • 13. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
    Lacson E, Wang W, Hakim RM, Teng M, Lazarus JM.
    Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
    [Abstract] [Full Text] [Related]

  • 14. The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management.
    Ortega T, Ortega F, Diaz-Corte C, Rebollo P, Ma Baltar J, Alvarez-Grande J.
    Nephrol Dial Transplant; 2005 Mar; 20(3):598-603. PubMed ID: 15647308
    [Abstract] [Full Text] [Related]

  • 15. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R, RISCAVID Study Group.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [Abstract] [Full Text] [Related]

  • 16. Comorbid conditions and gender impact the primary survival of distal radio-cephalic arteriovenous fistula inpatients on long-term hemodialysis.
    Vernaglione L, Mele G, Cristofano C, Distratis C, Perrone F, Frascina M, Pennacchiotti F, Chimienti S.
    J Nephrol; 2005 Jul; 18(3):276-81. PubMed ID: 16013015
    [Abstract] [Full Text] [Related]

  • 17. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008.
    Spiegel DM, Khan I, Krishnan M, Mayne TJ.
    Am J Kidney Dis; 2010 Jan; 55(1):113-20. PubMed ID: 19932539
    [Abstract] [Full Text] [Related]

  • 18. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Fang W, Oreopoulos DG, Bargman JM.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
    [Abstract] [Full Text] [Related]

  • 19. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS.
    Saran R, Dykstra DM, Pisoni RL, Akiba T, Akizawa T, Canaud B, Chen K, Piera L, Saito A, Young EW.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2334-40. PubMed ID: 15252160
    [Abstract] [Full Text] [Related]

  • 20. Prediction of time-averaged concentration of haemoglobin in haemodialysis patients.
    Krisper P, Quehenberger F, Schneditz D, Holzer H, Polaschegg HD.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2082-7. PubMed ID: 13679484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.